3-aminomethyl-pyrrolidines as N-type calcium channel blockers

Details for Australian Patent Application No. 2004243511 (hide)

Owner Neuromed Technologies, Inc

Inventors Pajouhesh, Hassan; Snutch, Terrance P.

Agent Blake Dawson Waldron

Pub. Number AU-A-2004243511

PCT Pub. Number WO2004/105750

Priority 60/474,864 30.05.03 US

Filing date 28 May 2004

Wipo publication date 9 December 2004

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 207/09 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/105750 Priority application(s): WO2004/105750

24 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004243513-Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents

2004243503-Implants comprising functionalized carbon surfaces